Abstract
Bacteriophages are viruses that specifically lyse bacteria. They have demonstrated potential in applications as antibacterial agents in medicine, agriculture, and environmental remediation. Due to the complex and dynamic nature of the oral microbiome, antibiotic treatment of chronic, polymicrobial oral diseases may lead to dysbiosis. In these diseases, bacteriophages may provide targeted activity against oral bacteria without such disruption to the broader microbial community. In this chapter, we describe the methods for screening samples that may contain bacteriophages against oral pathogenic bacteria, and using the example of FNU1, the bacteriophage we isolated against Fusobacterium nucleatum, describe the process of bacteriophage purification and characterization.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Han YW (2015) Fusobacterium nucleatum: a commensal-turned pathogen. Curr Opin Microbiol 23:141–147. https://doi.org/10.1016/j.mib.2014.11.013
Rickard AH, Gilbert P, High NJ, Kolenbrander PE, Handley PS (2003) Bacterial coaggregation: an integral process in the development of multi-species biofilms. Trends Microbiol 11(2):94–100. https://doi.org/10.1016/s0966-842x(02)00034-3
Han YW, Shi W, Huang GT, Kinder Haake S, Park NH, Kuramitsu H et al (2000) Interactions between periodontal bacteria and human oral epithelial cells: fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun 68(6):3140–3146. https://doi.org/10.1128/iai.68.6.3140-3146.2000
Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35(4):322–332. https://doi.org/10.1016/j.ijantimicag.2009.12.011
Imbuluzqueta E, Gamazo C, Ariza J, Blanco-Prieto MJ (2010) Drug delivery systems for potential treatment of intracellular bacterial infections. Front Biosci (Landmark Ed) 15:397–417. https://doi.org/10.2741/3627
Kilian M (2018) The oral microbiome - friend or foe? Eur J Oral Sci 126(Suppl 1):5–12. https://doi.org/10.1111/eos.12527
Dicks LMT, Mikkelsen LS, Brandsborg E, Marcotte H (2019) Clostridium difficile, the difficult “Kloster” fuelled by antibiotics. Curr Microbiol 76(6):774–782. https://doi.org/10.1007/s00284-018-1543-8
Theochari NA, Stefanopoulos A, Mylonas KS, Economopoulos KP (2018) Antibiotics exposure and risk of inflammatory bowel disease: a systematic review. Scand J Gastroenterol 53(1):1–7. https://doi.org/10.1080/00365521.2017.1386711
Roubaud-Baudron C, Ruiz VE, Swan AM, Vallance BA, Ozkul C, Pei Z et al (2019) Long-term effects of early-life antibiotic exposure on resistance to subsequent bacterial infection. mBio 10(6). https://doi.org/10.1128/mBio.02820-19
Boursi B, Mamtani R, Haynes K, Yang Y (2015) Recurrent antibiotic exposure may promote cancer formation—another step in understanding the role of the human microbiota? Eur J Cancer 51(17):2655–2664. https://doi.org/10.1016/j.ejca.2015.08.015
Dodds DR (2017) Antibiotic resistance: a current epilogue. Biochem Pharmacol 134:139–146. https://doi.org/10.1016/j.bcp.2016.12.005
Gordillo Altamirano FL, Barr JJ (2019) Phage therapy in the postantibiotic era. Clin Microbiol Rev 32(2). https://doi.org/10.1128/CMR.00066-18
Vandenheuvel D, Lavigne R, Brussow H (2015) Bacteriophage therapy: advances in formulation strategies and human clinical trials. Annu Rev Virol 2(1):599–618. https://doi.org/10.1146/annurev-virology-100114-054915
Shabbir MA, Hao H, Shabbir MZ, Wu Q, Sattar A, Yuan Z (2016) Bacteria vs. bacteriophages: parallel evolution of immune arsenals. Front Microbiol 7:1292. https://doi.org/10.3389/fmicb.2016.01292
Batinovic S, Wassef F, Knowler SA et al (2019) Bacteriophages in natural and artificial environments. Pathogens 8(3). https://doi.org/10.3390/pathogens8030100
Machuca P, Daille L, Vinés E, Berrocal L, Bittner M (2010) Isolation of a novel bacteriophage specific for the periodontal pathogen Fusobacterium nucleatum. Appl Environ Microbiol 76(21):7243–7250. https://doi.org/10.1128/AEM.01135-10
Kabwe M, Brown TL, Dashper S, Speirs L, Ku H, Petrovski S et al (2019) Genomic, morphological and functional characterisation of novel bacteriophage FNU1 capable of disrupting Fusobacterium nucleatum biofilms. Sci Rep 9(1):9107. https://doi.org/10.1038/s41598-019-45549-6
Khalifa L, Shlezinger M, Beyth S, Houri-Haddad Y, Coppenhagen-Glazer S, Beyth N et al (2016) Phage therapy against Enterococcus faecalis in dental root canals. J Oral Microbiol 8:32157. https://doi.org/10.3402/jom.v8.32157
Hillman ET, Lu H, Yao T, Nakatsu C (2017) Microbial ecology along the gastrointestinal tract. Microbes Environ 32(4):300–313. https://doi.org/10.1264/jsme2.ME17017
Zheng DW, Dong X, Pan P, Chen KW, Fan JX, Cheng SX et al (2019) Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy. Nat Biomed Eng 3(9):717–728. https://doi.org/10.1038/s41551-019-0423-2
Schneider C, Zemp E, Zitzmann NU (2019) Dental care behaviour in Switzerland. Swiss Dent J 129(6):466–478
Fernandez CE, Fontana M, Samarian D, Cury JA, Rickard AH, González-Cabezas C (2016) Effect of fluoride-containing toothpastes on enamel demineralization and Streptococcus mutans biofilm architecture. Caries Res 50(2):151–158. https://doi.org/10.1159/000444888
Ardizzoni A, Pericolini E, Paulone S, Orsi CF, Castagnoli A, Oliva I et al (2018) In vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity. PLoS One 13(11):e0207262. https://doi.org/10.1371/journal.pone.0207262
Brown TL, Ku H, Mnatzaganian G, Angove M, Petrovski S, Kabwe M et al (2020) The varying effects of a range of preservatives on Myoviridae and Siphoviridae bacteriophages formulated in a semi-solid cream preparation. Lett Appl Microbiol. https://doi.org/10.1111/lam.13299
Castillo DE, Nanda S, Keri JE (2018) Propionibacterium (Cutibacterium) acnes bacteriophage therapy in acne: current evidence and future perspectives. Dermatol Ther (Heidelb). https://doi.org/10.1007/s13555-018-0275-9
Garretto A, Miller-Ensminger T, Wolfe AJ, Putonti C (2019) Bacteriophages of the lower urinary tract. Nat Rev Urol 16(7):422–32. https://doi.org/10.1038/s41585-019-0192-4
Letkiewicz S, Miedzybrodzki R, Klak M, Jonczyk E, Weber-Dabrowska B, Górski A (2010) The perspectives of the application of phage therapy in chronic bacterial prostatitis. FEMS Immunol Med Microbiol 60(2):99–112. https://doi.org/10.1111/j.1574-695X.2010.00723.x
Chang RYK, Wallin M, Lin Y, Leung SSY, Wang H, Morales S et al (2018) Phage therapy for respiratory infections. Adv Drug Deliv Rev 133:76–86. https://doi.org/10.1016/j.addr.2018.08.001
Vazquez R, Garcia E, Garcia P (2018) Phage lysins for fighting bacterial respiratory infections: a new generation of antimicrobials. Front Immunol 9:2252. https://doi.org/10.3389/fimmu.2018.02252
Lopetuso LR, Giorgio ME, Saviano A, Scaldaferri F, Gasbarrini A, Cammarota G (2019) Bacteriocins and bacteriophages: therapeutic weapons for gastrointestinal diseases? Int J Mol Sci 20(1). https://doi.org/10.3390/ijms20010183
Shkoporov AN, Hill C (2019) Bacteriophages of the human gut: the “known unknown” of the microbiome. Cell Host Microbe 25(2):195–209. https://doi.org/10.1016/j.chom.2019.01.017
Shkoporov AN, Khokhlova EV, Fitzgerald CB, Stockdale SR, Draper LA, Ross RP et al (2018) PhiCrAss001 represents the most abundant bacteriophage family in the human gut and infects Bacteroides intestinalis. Nat Commun 9(1):4781. https://doi.org/10.1038/s41467-018-07225-7
Khan Mirzaei M, Khan MAA, Ghosh P, Taranu ZE, Taguer M, Ru J et al (2020) Bacteriophages isolated from stunted children can regulate gut bacterial communities in an age-specific manner. Cell Host Microbe 27(2):199–212.e5. https://doi.org/10.1016/j.chom.2020.01.004
Mitchell HL, Dashper SG, Catmull DV, Paolini RA, Cleal SM, Slakeski N et al (2010) Treponema denticola biofilm-induced expression of a bacteriophage, toxin-antitoxin systems and transposases. Microbiology 156(Pt 3):774–788. https://doi.org/10.1099/mic.0.033654-0
Baker JL, Hendrickson EL, Tang X, Lux R, He X, Edlund A et al (2019) Klebsiella and Providencia emerge as lone survivors following long-term starvation of oral microbiota. Proc Natl Acad Sci U S A 116(17):8499–8504. https://doi.org/10.1073/pnas.1820594116
Chen T, Olsen I (2019) Porphyromonas gingivalis and its CRISPR-Cas system. J Oral Microbiol 11(1):1638196. https://doi.org/10.1080/20002297.2019.1638196
van der Ploeg JR (2009) Analysis of CRISPR in Streptococcus mutans suggests frequent occurrence of acquired immunity against infection by M102-like bacteriophages. Microbiology 155(Pt 6):1966–1976. https://doi.org/10.1099/mic.0.027508-0
Hyman P, Abedon ST (2010) Bacteriophage host range and bacterial resistance. Adv Appl Microbiol 70:217–248. https://doi.org/10.1016/S0065-2164(10)70007-1
Hyman P (2019) Phages for phage therapy: isolation, characterization, and host range breadth. Pharmaceuticals (Basel) 12(1). https://doi.org/10.3390/ph12010035
Branston SD, Wright J, Keshavarz-Moore E (2015) A non-chromatographic method for the removal of endotoxins from bacteriophages. Biotechnol Bioeng 112(8):1714–1719. https://doi.org/10.1002/bit.25571
Ackermann HW, Audurier A, Berthiaume L, Jones LA, Mayo JA, Vidaver AK (1978) Guidelines for bacteriophage characterization. Adv Virus Res 23:1–24. https://doi.org/10.1016/s0065-3527(08)60096-2
Kutter E (2009) Phage host range and efficiency of plating. Methods Mol Biol (Clifton, NJ) 501:141–149. https://doi.org/10.1007/978-1-60327-164-6_14
Nelson PS, Papas TS, Schweinfest CW (1993) Restriction endonuclease cleavage of 5-methyl-deoxycytosine hemimethylated DNA at high enzyme-to-substrate ratios. Nucleic Acids Res 21(3):681–686. https://doi.org/10.1093/nar/21.3.681
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Kabwe, M., Brown, T., Ku, H., Dashper, S., Tucci, J. (2021). Isolation and Functional Characterization of Fusobacterium nucleatum Bacteriophage. In: Adami, G.R. (eds) The Oral Microbiome. Methods in Molecular Biology, vol 2327. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1518-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1518-8_4
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1517-1
Online ISBN: 978-1-0716-1518-8
eBook Packages: Springer Protocols